-
1
-
-
0023268502
-
The efficacy of Complex - A double-blind, placebocontrolled trial
-
Fischl, M. A.; Richman, D. D.; Grieco, M. H.; Gottlieb, M. S.; Volberding, P. A.; Laskin, O. L.; Leedom, J. M.; Groopman, J. E.; Mildvan, D.; Schooley, R. T.; Jackson, G. G.; Durack, D. T.; King, D. The efficacy of Complex - A double-blind, placebocontrolled trial. N. Engl. J. Med. 1987, 317, 185-191.
-
(1987)
N. Engl. J. Med.
, vol.317
, pp. 185-191
-
-
Fischl, M.A.1
Richman, D.D.2
Grieco, M.H.3
Gottlieb, M.S.4
Volberding, P.A.5
Laskin, O.L.6
Leedom, J.M.7
Groopman, J.E.8
Mildvan, D.9
Schooley, R.T.10
Jackson, G.G.11
Durack, D.T.12
King, D.13
-
2
-
-
0023266214
-
-
Richman, D. D.; Fischl, M. A.; Grieco, M. H.; Gottlieb, M. S.; Volberding, P. A.; Laskin, O. L.; Leedom, J. M.; Groopman, J. E.; Mildvan, D.; Hirsch, M. S.; Jackson, G. G.; Durack, D. T.; Nusinofflehrman, S. N. Engl. J. Med. 1987, 317, 192-197.
-
(1987)
N. Engl. J. Med.
, vol.317
, pp. 192-197
-
-
Richman, D.D.1
Fischl, M.A.2
Grieco, M.H.3
Gottlieb, M.S.4
Volberding, P.A.5
Laskin, O.L.6
Leedom, J.M.7
Groopman, J.E.8
Mildvan, D.9
Hirsch, M.S.10
Jackson, G.G.11
Durack, D.T.12
Nusinofflehrman, S.13
-
3
-
-
0028220406
-
Synthesis and antiviral activity of 3′-azido-3′-deoxythymidine triphosphate distearoylglycerol: A novel phospholipid conjugate of the anti-HIV agent AZT
-
Van Wijk, G. M; T.; Hostetler, K. Y.; Kroneman, E.; Richman, D. D.; Sridhar, C. N.; Kumar, R.; van der Bosch, H. Synthesis and antiviral activity of 3′-azido-3′-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT. Chem. Phys. Lipids 1994, 70, 213-222.
-
(1994)
Chem. Phys. Lipids
, vol.70
, pp. 213-222
-
-
Van Wijk, G.M.T.1
Hostetler, K.Y.2
Kroneman, E.3
Richman, D.D.4
Sridhar, C.N.5
Kumar, R.6
Van Der Bosch, H.7
-
4
-
-
0026662054
-
Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3′-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3′-deoxythymidine
-
Hostetler, K. Y.; Richman, D. D.; Carson, D. A.; Stuhmiller, L. M.; van Wijk, G. M. T.; van den Bosch, H. Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3′-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3′-deoxythymidine. Antimicrob. Agents Chemother. 1992, 36, 2025-2029.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 2025-2029
-
-
Hostetler, K.Y.1
Richman, D.D.2
Carson, D.A.3
Stuhmiller, L.M.4
Van Wijk, G.M.T.5
Van Den Bosch, H.6
-
5
-
-
0025814856
-
Lipophilic glycosyl phosphotriester derivatives of AZT: Synthesis, NMR transmembrane transport study, and antiviral activity
-
Benin, Y.; Gouyette, C.; Schwartz, O.; Debouzy, J.-C.; Neumann, J.-M.; Huynh-Dinh, T. Lipophilic glycosyl phosphotriester derivatives of AZT: Synthesis, NMR transmembrane transport study, and antiviral activity. J. Med. Chem. 1991, 34, 1830-1837.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 1830-1837
-
-
Benin, Y.1
Gouyette, C.2
Schwartz, O.3
Debouzy, J.-C.4
Neumann, J.-M.5
Huynh-Dinh, T.6
-
6
-
-
0025895220
-
Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity
-
Piantadosi, C.; Marasco, C. J., Jr.; Morris-Natschke, S. L.; Meyer, K. L.; Gumus, M. E. Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity. J. Med. Chem. 1991, 34, 1408-1414.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 1408-1414
-
-
Piantadosi, C.1
Marasco Jr., C.J.2
Morris-Natschke, S.L.3
Meyer, K.L.4
Gumus, M.E.5
-
7
-
-
0027050423
-
O-Alkyl-5′,5′-dinucleoside phosphates as prodrugs of 3′-azidothymidine and cordycepin
-
Meier, C.; Neumann, J.-M.; Andre, F.; Hennin, Y.; Huynh-Dinh, T. O-Alkyl-5′,5′-dinucleoside phosphates as prodrugs of 3′-azidothymidine and cordycepin. J. Org. Chem. 1992, 57, 7300-7308.
-
(1992)
J. Org. Chem.
, vol.57
, pp. 7300-7308
-
-
Meier, C.1
Neumann, J.-M.2
Andre, F.3
Hennin, Y.4
Huynh-Dinh, T.5
-
8
-
-
0027433373
-
Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process
-
Puech, F.; Gosselin, G.; Lefebvre, I.; Pompon, A.; Aubertin, A. M.; Kirn, A.; Imbach, J. L. Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process. Antiviral Res. 1993, 22, 155-174.
-
(1993)
Antiviral Res.
, vol.22
, pp. 155-174
-
-
Puech, F.1
Gosselin, G.2
Lefebvre, I.3
Pompon, A.4
Aubertin, A.M.5
Kirn, A.6
Imbach, J.L.7
-
9
-
-
0027412437
-
Synthesis and anti-HIV evaluation of D4T and D4T 5′-monophosphate prodrugs
-
Sergheraert, C.; Pierlot, C.; Tartar, A.; Henin, Y.; Lemaitre, M. Synthesis and anti-HIV evaluation of D4T and D4T 5′-monophosphate prodrugs. J. Med. Chem. 1993, 36, 826-830.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 826-830
-
-
Sergheraert, C.1
Pierlot, C.2
Tartar, A.3
Henin, Y.4
Lemaitre, M.5
-
10
-
-
0028258723
-
Diaryl phosphate derivatives act as pro-drugs of AZT with reduced cytotoxicity compared to the parent nucleoside
-
McGuigan, C.; Pathirana, R. N.; Davies, M. P. H.; Balzarini, J.; De Clercq, E. Diaryl phosphate derivatives act as pro-drugs of AZT with reduced cytotoxicity compared to the parent nucleoside. Bioorg. Med. Chem. Lett. 1994, 4, 427-430.
-
(1994)
Bioorg. Med. Chem. Lett.
, vol.4
, pp. 427-430
-
-
McGuigan, C.1
Pathirana, R.N.2
Davies, M.P.H.3
Balzarini, J.4
De Clercq, E.5
-
11
-
-
0027284753
-
Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT
-
McGuigan, C.; Pathirana, R. N.; Balzarini, J.; De Clercq, E. Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT. J. Med. Chem. 1993, 36, 1048-1052.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 1048-1052
-
-
McGuigan, C.1
Pathirana, R.N.2
Balzarini, J.3
De Clercq, E.4
-
12
-
-
37049072276
-
Synthesis, bioactivation and anti-HIV activity of the bis(4-acyloxybenzyl) and mono(4-acyloxybenzyl) esters of the 5′ monophosphate of AZT
-
Thomson, W.; Nicholls, D.; Irwin, W. J.; Al-Mushadani, J.; Freeman, S.; Karpas, A.; Petrik, J.; Mahmood, N.; Hay, A. J. Synthesis, bioactivation and anti-HIV activity of the bis(4-acyloxybenzyl) and mono(4-acyloxybenzyl) esters of the 5′ monophosphate of AZT. J. Chem. Soc., Perkin Trans, 1 1993, 1239-1245.
-
(1993)
J. Chem. Soc., Perkin Trans, 1
, pp. 1239-1245
-
-
Thomson, W.1
Nicholls, D.2
Irwin, W.J.3
Al-Mushadani, J.4
Freeman, S.5
Karpas, A.6
Petrik, J.7
Mahmood, N.8
Hay, A.J.9
-
13
-
-
0028833056
-
Synthesis and anti-HIV evaluation of alkyl and alkoxyethyl phosphodiester AZT derivatives
-
Calogeropoulou, T.; Koufaki, M.; Tsotinis, A.; Balzarini, J.; De Clerq, E.; Makriyannis, A. Synthesis and anti-HIV evaluation of alkyl and alkoxyethyl phosphodiester AZT derivatives. Antiviral Chem. Chemother. 1995, 6, 43-49.
-
(1995)
Antiviral Chem. Chemother.
, vol.6
, pp. 43-49
-
-
Calogeropoulou, T.1
Koufaki, M.2
Tsotinis, A.3
Balzarini, J.4
De Clerq, E.5
Makriyannis, A.6
-
14
-
-
0021237243
-
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
-
Popovic, M.; Sarngadharan, M. C.; Read, E.; Gallo, R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224, 497-500.
-
(1984)
Science
, vol.224
, pp. 497-500
-
-
Popovic, M.1
Sarngadharan, M.C.2
Read, E.3
Gallo, R.C.4
-
15
-
-
0025979184
-
9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus-infection in rhesus-monkeys
-
Balzarini, J.; Naesens, L.; Slachmuylders, J.; Niphuis, H.; Rosenberg, I.; Holy, A.; Schellekens, H.; De Clercq, E. 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus-infection in rhesus-monkeys. AIDS 1991, 5, 21-28.
-
(1991)
AIDS
, vol.5
, pp. 21-28
-
-
Balzarini, J.1
Naesens, L.2
Slachmuylders, J.3
Niphuis, H.4
Rosenberg, I.5
Holy, A.6
Schellekens, H.7
De Clercq, E.8
-
16
-
-
10144224034
-
-
note
-
50 (50% cytotoxic concentration) is the concentration of compound which causes a 50% reduction in cell viability. The SI (selectivity index) is the ratio of 50% cytotoxic concentration to 50% antivirally effective concentration. For full details, see ref 15.
-
-
-
|